stockportfolio.pro
Stocks / BAX vs MASI
BAX vs MASI
Baxter International Inc. and Masimo Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
BAX is the larger company ($10.0B vs $9.4B). On the fundamentals, MASI grows revenue faster (5.9% vs -0.7%); BAX earns a higher net margin (-8.5% vs -9.9%); BAX has the stronger return on equity (-15.6% vs -21.0%). Full numbers below — the stronger figure on each row is in green.
| Baxter International Inc. (BAX) | Masimo Corporation (MASI) | |
|---|---|---|
| Market cap | $10.0B | $9.4B |
| Revenue (latest FY) | $11.24B | $1.53B |
| Net income (latest FY) | $-957.00M | $-151.50M |
| Revenue growth (5y CAGR) | -0.7% | 5.9% |
| Net margin | -8.5% | -9.9% |
| Return on equity | -15.6% | -21.0% |
| P/E ratio | — | 44.4 |
| Dividend yield | 1.0% | — |
| Profitable years (of last 10) | 7 | 8 |
| Positive free cash flow | Yes | Yes |
Compare with another company:
See the full BAX vs MASI breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open BAX's full financials → Open MASI's full financials →More comparisons
Frequently asked questions
Which is bigger, BAX or MASI?
Baxter International Inc. is larger by market capitalization — $10.0B versus $9.4B.
Which grows faster, BAX or MASI?
Over the last five fiscal years, Masimo Corporation grew revenue faster — 5.9%/yr versus -0.7%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.